Aragon Research Inc

Established in 1997, Applied Wireless Identifications Group is a radio frequency identification device component and subsystem supplier to the RFID industry. The company provides products in access and security markets and in asset and logistic markets. It provides customers with access control readers and one of the world's highest performance multiple protocol RFID readers for asset and logistic solutions. The company provides a line of RFID readers for all applications, such as access/security, asset/logistics, handheld, fixed location, portal and shelf readers. It provides a variety of products to its customers that include access control products, such as readers, long-range readers, cards and tags, long-range cards and tags and accessories; and asset management products, such as readers, tags and accessories. Applied Wireless Identifications Group is headquartered in Monsey, N.Y.

Aragen Bioscience is a prominent research and development partner for the global biotech industry, focusing on accelerating innovation and product development from initial concepts to clinical applications. With a dedicated team and advanced technology platforms, the company operates two campuses in the San Francisco Bay Area, specializing in biologics solutions, preclinical efficacy testing, and a diverse range of therapeutic areas. Committed to fostering partnerships with biotechnology companies, health organizations, and academic institutions, Aragen supports a multitude of projects including recombinant protein production, biosimilar development, and animal health improvements. Their expertise and comprehensive services ensure quality outcomes and facilitate the transformation of scientific research into viable therapeutic solutions. Generated from the website

The Global Cancer Research Institute (GCRI), located in Northern California, is a pioneering community-based clinical trial unit that specializes in Hematology and Medical Oncology. It provides patients access to innovative cancer therapies and collaborates closely with academia, community physicians, and biotechnology companies to expedite the development of life-saving treatments. Committed to personalized care, GCRI emphasizes individualized treatment plans that cater to the unique needs of each patient in a nurturing environment. The institute also operates the GCRI Foundation, a non-profit organization focused on funding research and providing educational support services for cancer patients and their families. Generated from the website